Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
Zhenghai Shen(Kunming Medical University), Yunchao Huang(North China University of Water Resources and Electric Power), Jingjing Cai(Anhui Institute of Architectural Research and Design), Jie Ma(Kunming Medical University), Lisa Pu, Xin Li(Third Affiliated Hospital of Southern Medical University), Shanshan Li(Kunming Medical University), Xi Liu(Wuhan University), Hongsheng Li(Chinese University of Hong Kong), Yanlong Yang(Kunming Medical University), Zhenghong Yang(Kunming Medical University), Xiaoxiong Wang(Qingdao University), Yongchun Zhou(Kunming Medical University), Zaoxiu Hu(Kunming Medical University)
Cited by 11
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
|Cell Reports|2016|382